In conclusion, our findings indicate that ALKBH5 is overexpressed in AML and contributes to ADR resistance by inhibiting m6A modification, thereby promoting TUG1 expression in a YTHDF2-dependent manner. The gene discussed is YTHDF2; the disease is acute myeloid leukemia.